Alexander Kenneth S, Thyagarajapuram N
College of Pharmacy, The Univeristy of Toledo, Toledo, Ohio.
Int J Pharm Compd. 2003 Sep-Oct;7(5):389-93.
Amiodarone is commercially available as both a tablet and an injectable formulation. It is widely dispensed as an extemporaneously compounded suspension for pediatric and geriatric patients. Extensive stability data at numerous temperatures and a calculated shelf life based on kinetics for such a formulation have not been reported. Refrigeration and room temperature data for finite times have been reported in the literature. In this study, a stable extemporaneous formulation of amiodarone hydrochloride was formulated using Paceron tablets. The formulation consisted of 0.75% carboxymethylcellulose and 0.75% Veegum as suspending agents; 25% sucrose, provided as simple syrup; and aqueous strawberry concentrate as flavor. A total of 2.5L of the formulation was compounded and stored in quanitites of 150 mL in 8-oz glass containers. The initial drug content was determined by reverse-phase high-performance liquid chromatography, with a method that was developed in our laboratory. The stability study was carried out by storing three containers at five different temperatures, namely 4, 30, 40, 50, and 60 deg C. The suspension was analyzed at the end of 2, 6, 12, 24, and 48 hours at 7 days, and, therafter, at the end of every week for 13 weeks. The percentage of drug remaining was plotted against time for each temperature. The slope of the regression line was obtained for each temperature and the zero-order degradation rate constant obtained. The logarithm of the zero-order degradation rate constants was plotted against the inverse of the temperature in degrees Kelvin to obtain the Arrhenius plot. From the regression line for the Arrhenius plot, the zero-order degradation constant at 25 deg C was calculated to be 0.0517 day -1. The shelf life for the formulation at 25 deg C was calculated to be 193.4 days; the shelf life under refrigeration (4 deg C) was found to be 677.3 days. The degradation products were characterized using high-performance liquid chromatographic-mass spectrometry. Data obtained from the analysis suggested that amiodarone cleaved at its ketone and ether linkages to yield corresponding degradation products.
胺碘酮有片剂和注射剂两种商业制剂。它广泛作为临时配制的混悬液用于儿科和老年患者。尚未有关于该制剂在众多温度下的广泛稳定性数据以及基于动力学计算的保质期的报道。文献中报道了有限时间内的冷藏和室温数据。在本研究中,使用可达龙片配制了一种稳定的盐酸胺碘酮临时制剂。该制剂由0.75%的羧甲基纤维素和0.75%的硅酸镁铝作为助悬剂;25%的蔗糖,以单糖浆形式提供;以及草莓浓缩水溶液作为调味剂。总共配制了2.5升该制剂,并以150毫升的量储存在8盎司的玻璃容器中。初始药物含量通过反相高效液相色谱法测定,该方法是在我们实验室开发的。稳定性研究通过将三个容器分别储存在五个不同温度下进行,即4、30、40、50和60℃。在第7天的2、6、12、24和48小时结束时对混悬液进行分析,此后,在13周内每周结束时进行分析。针对每个温度绘制药物剩余百分比与时间的关系图。获得每个温度下回归线的斜率并得到零级降解速率常数。将零级降解速率常数的对数与开尔文温度的倒数绘制关系图以获得阿仑尼乌斯图。根据阿仑尼乌斯图的回归线,计算出25℃下的零级降解常数为0.0517天-1。该制剂在25℃下的保质期计算为193.4天;在冷藏(4℃)条件下的保质期为677.3天。使用高效液相色谱-质谱联用对降解产物进行了表征。分析获得的数据表明,胺碘酮在其酮键和醚键处断裂,产生相应的降解产物。